- Multimodal Treatment of Sarcomas Linked to BCOR-CCNB3 Fusion in Pediatrics: A 3-Patient Case Series
-
Omar S, Albritton K, Heym K, Wang J, Ray A
- KMID: 2534764
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):60-64.
- doi: 10.15264/cpho.2022.29.2.60
In 2012, a new neoplasm was classified according to fusion of the B-cell lymphoma (BCL-6) corepressor (BCOR) gene and the testis-specific cyclin B3 (CCNB3) gene on the X-chromosome, known as... -
- CITED
-
- Close
- SHARE
-
- Close
- Pyridoxine Refractory Sideroblastic Anemia: Diagnosis and Misdiagnosis
-
Alam MM, Alathaibi A, Attar RA, Kashif M, Al-Ghamdi HS, Alharthi SA, Bokhary A, Althomali M
- KMID: 2534765
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):65-69.
- doi: 10.15264/cpho.2022.29.2.65
We report the case of a 7-year-old girl who was originally diagnosed at the age of 6 months with transfusion-dependent red cell aplasia based on a combination of severe anemia,... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Neurodegenerative Disease after Use of Vemurafenib in Refractory BRAF V600E-Mutated Langerhans Cell Histiocytosis: A Case Report
-
Koh YK, Yoon SH, Kang SH, Kim H, Im HJ, Kim PH, Jung AY, Koh KN
- KMID: 2534772
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):97-101.
- doi: 10.15264/cpho.2022.29.2.97
Langerhans cell histiocytosis (LCH) is a rare histiocytic disorder characterized by heterogenous lesions infiltrated with CD1a+/CD207+ cells. Although LCH has a relatively good prognosis, the prognosis for patients with LCH... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Procedures Requiring Hospitalization and Perioperative Management for Patients with Hereditary Bleeding Disorders
-
Seo HS, Ahn WK, Hahn SM, Han JW, Lyu CJ
- KMID: 2534763
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):52-59.
- doi: 10.15264/cpho.2022.29.2.52
Background: Hemophilia requires a lifetime care for bleeding control and complications. Although patients diagnosed with hemophilia receive factor replacement, they also experience a variety of medical problems as they age.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of B-cell Precursor Acute Lymphoblastic Leukemia with the t(14;22)(q32;q11) Presenting Hyperleukocytosis
-
Lee J, Kim SY, Lim YJ
- KMID: 2534770
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):89-91.
- doi: 10.15264/cpho.2022.29.2.89
B-cell precursor acute lymphoblastic leukemia (BCP-ALL), which is the most common type of ALL, has an excellent prognosis with long-term event-free survival of 90%. The malignancy has several genetic abnormalities that... -
- CITED
-
- Close
- SHARE
-
- Close
- IVIG Treatment Response and Age are Important for the Prognosis of Pediatric Immune Thrombocytopenia
-
Sakong MG, Park JH, Son SB, Kim YK, Lee JM
- KMID: 2534762
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):44-51.
- doi: 10.15264/cpho.2022.29.2.44
Background: This study aimed to identify chronicity predictors of pediatric primary immune thrombocytopenia (ITP). Methods: This study retrospectively reviewed the medical records of patients with primary pediatric ITP admitted to a... -
- CITED
-
- Close
- SHARE
-
- Close
- Anakinra to Mitigate Hemophagocytic Lymphohistiocytosis-Like Toxicity Following Chimeric Antigen Receptor T-cell Therapy in Pediatric B-cell ALL
-
Lee NY, Jo S, Yoo JW, Kim S, Lee JW, Chung NG, Cho B
- KMID: 2534771
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):92-96.
- doi: 10.15264/cpho.2022.29.2.92
Hemophagocytic lymphohistiocytosis-like toxicity following chimeric antigen receptor (CAR)-T cell therapy (carHLH) is a rare and fulminant complication. Currently, there are neither well-established diagnostic criteria nor optimal treatment option for carHLH.... -
- CITED
-
- Close
- SHARE
-
- Close
- Central Precocious Puberty Following Treatment of Precocious Pseudo-Puberty Caused by Leydig Cell Tumor: A Pediatric Case and Literature Review
-
Ahn JH, Park JK, Jung SJ, Lee JE
- KMID: 2534767
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):74-78.
- doi: 10.15264/cpho.2022.29.2.74
Leydig cell tumors can cause precocious puberty in prepubertal males. Radical orchiectomy is the standard therapy for Leydig cell tumors, with a good overall prognosis. Here, we present a rare case... -
- CITED
-
- Close
- SHARE
-
- Close
- How I Treat Primary Immune Deficiencies with Hematopoietic Stem Cell Transplantation
-
Kook H, Kim B, Baek HJ
- KMID: 2534761
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):35-43.
- doi: 10.15264/cpho.2022.29.2.35
Primary immune deficiencies (PID), or more recently, inborn errors of immunity (IEI), resulting from genetic defects of the immune system may present with increased susceptibility to infections, persistent inflammation, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Isolated Central Nervous System Relapse with Intrathecal Chemotherapy in an Adolescent with Acute Promyelocytic Leukemia
-
Song H, Yi ES
- KMID: 2534766
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):70-73.
- doi: 10.15264/cpho.2022.29.2.70
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) characterized by translocation of chromosomes 15 and 17 (t(15;17)), which rarely occurs in the pediatric population. Isolated central... -
- CITED
-
- Close
- SHARE
-
- Close
- EBV Associated Lymphomatoid Granulomatosis in 18-Year-Old Male: A Case Report
-
Jung ES, Bae EY, Roh EJ, Chung EH, You SK, Kim JM, Kim M, Lim YJ
- KMID: 2534769
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):84-88.
- doi: 10.15264/cpho.2022.29.2.84
Lymphomatoid granulomatosis (LYG) is an Epstein-Barr virus (EBV)-associated lymphoproliferative disease. It is considered a rare entity in pediatric patients. An adolescent male with lobar consolidation suspected of having pneumonia was... -
- CITED
-
- Close
- SHARE
-
- Close
- Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Resembling Recurrent Follicular Lymphoma: A Case Report
-
Park CH, Choi YB
- KMID: 2534768
- Clin Pediatr Hematol Oncol.
- 2022 Oct;29(2):79-83.
- doi: 10.15264/cpho.2022.29.2.79
Epstein-Barr virus (EBV)-associated lymphoproliferative diseases represent various clinical manifestations. EBV-associated hemophagocytic lymphohistiocytosis (HLH) and lymphoma are difficult to distinguish due to overlapping characteristics between these two diseases. Here, we present... -
- CITED
-
- Close
- SHARE
-
- Close
